YD Bio Limited Ordinary Shares
YDES · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $510 | $350 | $0 | $0 |
| % Growth | 45.8% | – | – | – |
| Cost of Goods Sold | $355 | $197 | $0 | $0 |
| Gross Profit | $155 | $153 | $0 | $0 |
| % Margin | 30.4% | 43.8% | – | – |
| R&D Expenses | $491 | $0 | $0 | $0 |
| G&A Expenses | $1,124 | $153 | $0 | $0 |
| SG&A Expenses | $1,126 | $161 | $2,323 | $1,722 |
| Sales & Mktg Exp. | $2 | $7 | $0 | $0 |
| Other Operating Expenses | -$0 | $3 | $0 | $0 |
| Operating Expenses | $1,617 | $163 | $2,323 | $1,722 |
| Operating Income | -$1,462 | -$10 | -$2,323 | -$1,722 |
| % Margin | -286.5% | -2.8% | – | – |
| Other Income/Exp. Net | $75 | $27 | $6,113 | $10,426 |
| Pre-Tax Income | -$1,386 | $18 | $3,790 | $8,704 |
| Tax Expense | $25 | $4 | $2 | $0 |
| Net Income | -$1,412 | $14 | $3,788 | $8,704 |
| % Margin | -276.6% | 3.9% | – | – |
| EPS | -0.56 | 0 | 0.41 | 0.59 |
| % Growth | -280,100% | -100% | -30.5% | – |
| EPS Diluted | -0.56 | 0 | 0.41 | 0.59 |
| Weighted Avg Shares Out | 4,146 | 70,095 | 9,294 | 14,631 |
| Weighted Avg Shares Out Dil | 4,146 | 70,095 | 9,294 | 14,631 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $0 | $1 | $1 |
| Interest Expense | $1 | $2 | $0 | $0 |
| Depreciation & Amortization | $105 | $2 | $0 | $0 |
| EBITDA | -$1,281 | $22 | $3,790 | $8,704 |
| % Margin | -251% | 6.4% | – | – |